Mei Ding

2.6k total citations · 2 hit papers
11 papers, 1.5k citations indexed

About

Mei Ding is a scholar working on Infectious Diseases, Oncology and Surgery. According to data from OpenAlex, Mei Ding has authored 11 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Mei Ding's work include COVID-19 Clinical Research Studies (3 papers), Allergic Rhinitis and Sensitization (2 papers) and Dermatology and Skin Diseases (2 papers). Mei Ding is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Allergic Rhinitis and Sensitization (2 papers) and Dermatology and Skin Diseases (2 papers). Mei Ding collaborates with scholars based in China, Switzerland and Germany. Mei Ding's co-authors include Milena Sokołowska, Cezmi A. Akdiş, Yadong Gao, Jinjin Zhang, Xiang Dong, Mübeccel Akdiş, Ahmet Kürşat Azkur, Willem van de Veen, Wei Fu and Yuanli Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Allergy.

In The Last Decade

Mei Ding

11 papers receiving 1.5k citations

Hit Papers

Risk factors for severe and critically ill COVID‐19 patie... 2020 2026 2022 2024 2020 2020 250 500 750

Peers

Mei Ding
Dilek Azkur Türkiye
Sarah Hochman United States
Pan Ji China
Li Niu China
Dilek Azkur Türkiye
Mei Ding
Citations per year, relative to Mei Ding Mei Ding (= 1×) peers Dilek Azkur

Countries citing papers authored by Mei Ding

Since Specialization
Citations

This map shows the geographic impact of Mei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Ding more than expected).

Fields of papers citing papers by Mei Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Ding. The network helps show where Mei Ding may publish in the future.

Co-authorship network of co-authors of Mei Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Ding. A scholar is included among the top collaborators of Mei Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Ding. Mei Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Huan, Guoqing Gong, Mei Ding, et al.. (2022). Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients. SHILAP Revista de lepidopterología. 2. 810133–810133. 2 indexed citations
2.
Wan, Qianqian, Shaojun He, Wenjuan Xu, et al.. (2022). IL-13 Regulates Orai1 Expression in Human Bronchial Smooth Muscle Cells and Airway Remodeling in Asthma Mice Model via LncRNA H19. Journal of Asthma and Allergy. Volume 15. 1245–1261. 4 indexed citations
3.
Dong, Xiang, Mei Ding, Jinjin Zhang, et al.. (2022). Involvement and therapeutic implications of airway epithelial barrier dysfunction in type 2 inflammation of asthma. Zurich Open Repository and Archive (University of Zurich). 17 indexed citations
4.
Acevedo, Nathalie, Bilal Alashkar Alhamwe, Luis Caraballo, et al.. (2021). Perinatal and Early-Life Nutrition, Epigenetics, and Allergy. Nutrients. 13(3). 724–724. 111 indexed citations
5.
Xu, Wenjuan, et al.. (2021). Store-operated calcium entry-associated regulatory factor regulates airway inflammation and airway remodeling in asthma mice models. American Journal of Physiology-Lung Cellular and Molecular Physiology. 321(3). L533–L544. 8 indexed citations
6.
Radzikowska, Urszula, Mei Ding, Ge Tan, et al.. (2020). Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors. Allergy. 75(11). 2829–2845. 387 indexed citations breakdown →
7.
Gao, Yadong, Mei Ding, Xiang Dong, et al.. (2020). Risk factors for severe and critically ill COVID‐19 patients: A review. Allergy. 76(2). 428–455. 850 indexed citations breakdown →
8.
Gao, Yadong, Mei Ding, Xiang Dong, et al.. (2020). Risk factors for severe and critically ill COVID-19 patients: a review. 66 indexed citations
9.
Ding, Mei, et al.. (2019). MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2–CCR2 Axis. Journal of Interferon & Cytokine Research. 39(4). 224–232. 25 indexed citations
10.
Ding, Mei, Yadong Gao, Xian‐Tao Zeng, Yi Guo, & Jiong Yang. (2017). Endobronchial one-way valves for treatment of persistent air leaks: a systematic review. Respiratory Research. 18(1). 186–186. 25 indexed citations
11.
Ding, Mei & Jiong Yang. (2014). Therapeutic vaccination for non-small-cell lung cancer: a meta-analysis. Medical Oncology. 31(4). 928–928. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026